FHLC Among Health Care ETFs
End-of-day Nov 19, 2026 · 32 Health care ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −5.4% | −1.3% | +0.4% | +15.2% | +17.5% | +47.6% | +37.0% | +192.9% | +307.9% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$146 of every $1,000 in FHLC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.61% | $1,461.14 | 421K | $581.6M |
| 2 | JNJJohnson & Johnson | Healthcare | 8.67% | $866.53 | 1.3M | $344.9M |
| 3 | ABBVAbbvie | Healthcare | 6.67% | $667.04 | 928K | $265.5M |
| 4 | MRKMerck & NEW | Healthcare | 4.49% | $449.20 | 1.3M | $178.8M |
| 5 | UNHUnitedhealth Group | Healthcare | 4.19% | $419.46 | 477K | $167.0M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.40% | $339.83 | 195K | $135.3M |
| 7 | AMGNAmgen | Healthcare | 3.16% | $316.25 | 284K | $125.9M |
| 8 | GILDGilead Sciences | Healthcare | 2.77% | $276.94 | 652K | $110.2M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.40% | $240.23 | 915K | $95.6M |
| 10 | PFEPfizer | Healthcare | 2.11% | $211.11 | 3.0M | $84.0M |
| 11 | ISRGIntuitive Surgical | Healthcare | 1.97% | $196.80 | 186K | $78.3M |
| 12 | DHRDanaher | Healthcare | 1.92% | $192.20 | 335K | $76.5M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.80% | $179.74 | 133K | $71.5M |
| 14 | 0Y6X.LMedtronic | Healthcare | 1.70% | $170.19 | 673K | $67.7M |
| 15 | MCKMckesson | Healthcare | 1.68% | $167.61 | 62K | $66.7M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.61% |
| 2 | JNJ | Johnson & Johnson | 8.67% |
| 3 | ABBV | Abbvie | 6.67% |
| 4 | MRK | Merck & NEW | 4.49% |
| 5 | UNH | Unitedhealth Group | 4.19% |
| 6 | TMO | Thermo Fisher Scientific | 3.40% |
| 7 | AMGN | Amgen | 3.16% |
| 8 | GILD | Gilead Sciences | 2.77% |
| 9 | ABT | Abbott Laboratories | 2.40% |
| 10 | PFE | Pfizer | 2.11% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |